PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Небольшая подборка полезной литературы

Опубликовано 6 марта, 201930 июня, 2019 frozencat

Data And Safety Monitoring Committees In Clinical Trials

Epidemiology and Biostatistics An Introduction to Clinical Research

Statistical Methods for Survival Trial Design: With Applications to Cancer Clinical Trials Using R

Clinical trial data analysis with R and SAS

Clinical Trials Design in Operative and Non Operative Invasive Procedures

Analyzing Longitudinal Clinical Trial Data: A Practical Guide

Bioequivalence and Statistics in Clinical Pharmacology, Second Edition

Design and Analysis of Bioavailability and Bioequivalence Studies

Biomaterials in Clinical Practice : Advances in Clinical Research and Medical Devices

Fundamental Statistical Inference A Computational Approach

Statistics and Simulation

Medical biostatistics

Biostatistics

Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development

Biosimilar Clinical Development: Scientific Considerations and New Methodologies

Рубрики: Блог, Общее

Навигация по записям

Предыдущая запись: Расчет доверительных интервалов для 2X2 биоэквивалентности: Julia concept code
Следующая запись: Протокол и отчет клинического исследования биоэквивалентности: шаблон

Свежие записи

  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0

Галерея

20180202 123629
IMG-20170806-WA0025
20180815 171827
20170801 175422
IMG-20170807-WA0004
DJI 0034
  • Advisory Letters
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-25 By FDA
  • Patient Engagement Collaborative
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-24 By FDA
  • FDA Investigating Deaths Due to Acute Liver Failure in Non-ambulatory Duchenne Muscular Dystrophy Patients Following ELEVIDYS
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-24 By FDA
  • Toki Slimming Candy may be harmful due to hidden drug ingredients
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-24 By FDA
  • Weight Loss Product Notifications
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-24 By FDA
  • FIBRYGA
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-24 By FDA
  • Ongoing | Cancer Accelerated Approvals
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-24 By FDA
  • Competitive Generic Therapy Approvals
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-24 By FDA
  • Pfizer-BioNTech COVID-19 Vaccine
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-24 By FDA
  • Moderna COVID-19 Vaccine
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-24 By FDA
  • Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-24
  • Human medicines European public assessment report (EPAR): Miglustat Gen.Orph, miglustat, Date of authorisation: 09/11/2017, Revision: 12, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-24
  • Laboratory Information Bulletins
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-24 By FDA
  • Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 3, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-24
  • Human medicines European public assessment report (EPAR): Aripiprazole Sandoz, aripiprazole, Date of authorisation: 20/08/2015, Revision: 12, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-24
Предыдущие записи
Тема: Scaffold от Danny Cooper.